Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04890210 |
Other study ID # |
DCiptoMGH Indonesia |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 20, 2021 |
Est. completion date |
December 1, 2021 |
Study information
Verified date |
May 2021 |
Source |
Dr Cipto Mangunkusumo General Hospital |
Contact |
Rabbinu R Pribadi, MD |
Phone |
+6285885382231 |
Email |
rabbinurangga[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
1. Objective The purpose of this study is to evaluate whether there is a significant
difference of early rebleeding rate (within the first 5 days after esophageal variceal
ligation), late rebleeding rate (more than 5 days until 28 days after esophageal
variceal ligation), and convenience level between cirrhotic patients in early diet group
versus late diet group.
2. Method This study is a single blind randomised clinical trial. Subjects will be selected
based on inclusion and exclusion criteria, then the subjects will be randomly divided
into 2 groups, the early diet group (clear fluid diet is initiated 1 hour after
esophageal variceal ligation) and the late diet group (clear fluid diet is initiated 6
hours after esophageal variceal ligation).
The intervention arm is the early diet group, while the control arm is the late diet
group. The primary outcome is the early rebleeding rate. The secondary outcomes are late
rebleeding rate and patient's convenience level which will be measured using Visual
Analogue Scale (VAS).
3. Expected result The expected result is there will be no difference in early bleeding
rate, late bleeding rate, and convenience level between early diet group versus late
diet group.
Description:
This study is a single blind randomised controlled trial (RCT) that will be conducted at
gastrointestinal endoscopy center division of gastroenterology, integrated procedure room
division of hepatobiliary, department of internal medicine, gastroenterology clinic,
hepatobiliary clinic, internal medicine ward, high care unit (HCU) and intensive care unit
(ICU) Cipto Mangunkusumo Hospital - Faculty of Medicine Universitas Indonesia from May 20,
2021-November 1, 2021. The proposed number of subjects are 130 patients.
Interventions will be given in the form of early clear fluid diet initiation compared to
active comparator in the form of late clear fluid diet initiation in eligible liver cirrhosis
patients who undergo esophageal variceal ligation (EVL) at Cipto Mangunkusumo Hospital. In
early diet group diet, the 100 ml of clear fluid will be initiated at 1 hour after EVL
followed by standard protocol (clear fluid, soft porridge, porridge, soft rice, regular rice)
explained in the arms and intervention column below. In late diet group, the 100 ml of clear
fluid will be initiated at 6 hours after EVL, followed by standard protocol (clear fluid,
soft porridge, porridge, soft rice, regular rice) explained in the arms and intervention
column below. Other routine and standardised drugs for liver cirrhosis patients will still be
given. Statistical analysis will use Chi square test with alternative Fisher test for
categorical dependent variables and independent T-test with alternative Mann-Whitney test for
two group numerical dependent variables.